{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:20Z","timestamp":1761513800776},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13000-016-0486-2","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T05:58:30Z","timestamp":1460613510000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma"],"prefix":"10.1186","volume":"11","author":[{"given":"Shintaro","family":"Sugita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"486_CR1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.seminoncol.2009.06.004","volume":"36","author":"F Mertens","year":"2009","unstructured":"Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, D'Incalci M, et al. Translocation-related sarcomas. Semin Oncol. 2009;36:312\u201323.","journal-title":"Semin Oncol"},{"key":"486_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1827.2011.02739.x","volume":"62","author":"Y Miura","year":"2012","unstructured":"Miura Y, Keira Y, Ogino J, Nakanishi K, Noguchi H, Inoue T, et al. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors. Pathol Int. 2012;62:16\u201327.","journal-title":"Pathol Int"},{"key":"486_CR3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(15)70098-7","volume":"16","author":"A Kawai","year":"2015","unstructured":"Kawai A, Araki N, Sugiura H, Ueda T, Yonemoto T, Takahashi M, et al. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Lancet Oncol. 2015;16:406\u201316.","journal-title":"Lancet Oncol"},{"key":"486_CR4","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1158\/1535-7163.MCT-10-0263","volume":"9","author":"M D'Incalci","year":"2010","unstructured":"D'Incalci M, Galmarini CM. A review of trabectedin (ET-743): a unique mechanism of action. Mol Cancer Ther. 2010;9:2157\u201363.","journal-title":"Mol Cancer Ther"},{"key":"486_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/1535-7163.MCT-08-0848","volume":"8","author":"C Forni","year":"2009","unstructured":"Forni C, Minuzzo M, Virdis E, Tamborini E, Simone M, Tavecchio M, et al. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. Mol Cancer Ther. 2009;8:449\u201357.","journal-title":"Mol Cancer Ther"},{"key":"486_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1470-2045(07)70175-4","volume":"8","author":"F Grosso","year":"2007","unstructured":"Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 2007;8:595\u2013602.","journal-title":"Lancet Oncol"},{"key":"486_CR7","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1016\/j.ejca.2012.05.012","volume":"48","author":"A Cesne Le","year":"2012","unstructured":"Le Cesne A, Cresta S, Maki RG, Blay JY, Verweij J, Poveda A, et al. A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas. Eur J Cancer. 2012;48:3036\u201344.","journal-title":"Eur J Cancer"},{"key":"486_CR8","first-page":"73","volume":"39","author":"VY Jo","year":"2015","unstructured":"Jo VY, Fletcher CD. Epithelioid malignant peripheral nerve sheath tumor: clinicopathologic analysis of 63 cases. Am J Surg Pathol. 2015;39:73\u201382.","journal-title":"Am J Surg Pathol"},{"key":"486_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/modpathol.3800489","volume":"19","author":"JC Fanburg-Smith","year":"2006","unstructured":"Fanburg-Smith JC, Majidi M, Miettinen M. Keratin expression in schwannoma; a study of 115 retroperitoneal and 22 peripheral schwannomas. Mod Pathol. 2006;19:115\u201321.","journal-title":"Mod Pathol"},{"key":"486_CR10","first-page":"747","volume":"11","author":"S Abe","year":"1998","unstructured":"Abe S, Imamura T, Park P, Nakano H, Okita H, Hata J, et al. Small round-cell type of malignant peripheral nerve sheath tumor. Mod Pathol. 1998;11:747\u201353.","journal-title":"Mod Pathol"},{"key":"486_CR11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1440-1827.2003.01492.x","volume":"53","author":"M Shintaku","year":"2003","unstructured":"Shintaku M, Nakade M, Hirose T. Malignant peripheral nerve sheath tumor of small round cell type with pleomorphic spindle cell sarcomatous areas. Pathol Int. 2003;53:478\u201382.","journal-title":"Pathol Int"},{"key":"486_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s004280000238","volume":"437","author":"M Miettinen","year":"2000","unstructured":"Miettinen M, Limon J, Niezabitowski A, Lasota J. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch. 2000;437:275\u201383.","journal-title":"Virchows Arch"},{"key":"486_CR13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/00000478-200211000-00005","volume":"26","author":"M Pelmus","year":"2002","unstructured":"Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60\u00a0t(X;18) (SYT-SSX)-positive cases. Am J Surg Pathol. 2002;26:1434\u201340.","journal-title":"Am J Surg Pathol"},{"key":"486_CR14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/pin.12022","volume":"62","author":"R Nakayama","year":"2012","unstructured":"Nakayama R, Miura Y, Ogino J, Susa M, Watanabe I, Horiuchi K, et al. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma. Pathol Int. 2012;62:823\u20136.","journal-title":"Pathol Int"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-016-0486-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:56:46Z","timestamp":1498287406000},"score":1,"resource":{"primary":{"URL":"http:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-016-0486-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1186\/s13000-016-0486-2","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"article-number":"37"}}